Share-based Payment Arrangement, Expense of WINDTREE THERAPEUTICS INC /DE/ from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
WINDTREE THERAPEUTICS INC /DE/ quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • WINDTREE THERAPEUTICS INC /DE/ Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $17,000, a 80% decline year-over-year.
  • WINDTREE THERAPEUTICS INC /DE/ Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $141,000, a 81% decline year-over-year.
  • WINDTREE THERAPEUTICS INC /DE/ annual Share-based Payment Arrangement, Expense for 2024 was $455,000, a 64% decline from 2023.
  • WINDTREE THERAPEUTICS INC /DE/ annual Share-based Payment Arrangement, Expense for 2023 was $1,278,000, a 59% decline from 2022.
  • WINDTREE THERAPEUTICS INC /DE/ annual Share-based Payment Arrangement, Expense for 2022 was $3,086,000, a 57% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

WINDTREE THERAPEUTICS INC /DE/ Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $141,000 $17,000 -$69,000 -80% 01 Jul 2025 30 Sep 2025 10-Q 19 Nov 2025 2025 Q3
Q2 2025 $210,000 $31,000 -$66,000 -68% 01 Apr 2025 30 Jun 2025 10-Q 19 Aug 2025 2025 Q2
Q1 2025 $276,000 $72,000 -$179,000 -71% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $455,000 $21,000 -$285,000 -93% 01 Oct 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
Q3 2024 $740,000 $86,000 -$219,000 -72% 01 Jul 2024 30 Sep 2024 10-Q 19 Nov 2025 2025 Q3
Q2 2024 $959,000 $97,000 -$285,000 -75% 01 Apr 2024 30 Jun 2024 10-Q 19 Aug 2025 2025 Q2
Q1 2024 $1,244,000 $251,000 -$34,000 -12% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 $1,278,000 $306,000 -$485,000 -61% 01 Oct 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 $1,763,000 $305,000 -$439,000 -59% 01 Jul 2023 30 Sep 2023 10-Q 26 Nov 2024 2024 Q3
Q2 2023 $2,202,000 $382,000 -$399,000 -51% 01 Apr 2023 30 Jun 2023 10-Q 19 Aug 2024 2024 Q2
Q1 2023 $2,601,000 $285,000 -$485,000 -63% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q4 2022 $3,086,000 $791,000 -$831,000 -51% 01 Oct 2022 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q3 2022 $3,917,000 $744,000 -$885,000 -54% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $4,802,000 $781,000 -$763,000 -49% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023 2023 Q2
Q1 2022 $5,565,000 $770,000 -$1,673,000 -68% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $7,238,000 $1,622,000 +$341,000 +27% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $6,897,000 $1,629,000 +$481,000 +42% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $6,416,000 $1,544,000 -$22,000 -1.4% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $6,438,000 $2,443,000 +$754,000 +45% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q4 2020 $5,684,000 $1,281,000 -$232,000 -15% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $5,916,000 $1,148,000 -$791,000 -41% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $6,707,000 $1,566,000 -$173,000 -9.9% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 $6,880,000 $1,689,000 +$159,000 +10% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $6,721,000 $1,513,000 +$1,261,000 +500% 01 Oct 2019 31 Dec 2019 10-K 29 Mar 2021 2020 FY
Q3 2019 $5,460,000 $1,939,000 +$1,794,000 +1237% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020 2020 Q3
Q2 2019 $3,666,000 $1,739,000 +$1,599,000 +1142% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020 2020 Q2
Q1 2019 $2,067,000 $1,530,000 +$1,112,000 +266% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q1
Q4 2018 $955,000 $252,000 -$577,000 -70% 01 Oct 2018 31 Dec 2018 10-K 03 Apr 2020 2019 FY
Q3 2018 $1,532,000 $145,000 -$33,000 -19% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2019 Q3
Q2 2018 $1,565,000 $140,000 -$114,000 -45% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019 2019 Q2
Q1 2018 $1,679,000 $418,000 +$118,000 +39% 01 Jan 2018 31 Mar 2018 10-Q 20 May 2019 2019 Q1
Q4 2017 $1,561,000 $829,000 +$532,000 +179% 01 Oct 2017 31 Dec 2017 10-K/A 23 Apr 2019 2018 FY
Q3 2017 $1,029,000 $178,000 -$95,000 -35% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3
Q2 2017 $1,124,000 $254,000 +$4,000 +1.6% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2
Q1 2017 $1,120,000 $300,000 -$303,000 -50% 01 Jan 2017 31 Mar 2017 10-Q 21 May 2018 2018 Q1
Q4 2016 $1,423,000 $297,000 -$47,000 -14% 01 Oct 2016 31 Dec 2016 10-K 17 Apr 2018 2017 FY
Q3 2016 $1,470,000 $273,000 -$145,000 -35% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017 2017 Q3
Q2 2016 $1,615,000 $250,000 -$85,000 -25% 01 Apr 2016 30 Jun 2016 10-Q 21 Aug 2017 2017 Q2
Q1 2016 $1,700,000 $603,000 +$4,000 +0.67% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1
Q4 2015 $1,696,000 $344,000 -$256,000 -43% 01 Oct 2015 31 Dec 2015 10-K 31 Mar 2017 2016 FY
Q3 2015 $1,952,000 $418,000 -$439,000 -51% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016 2016 Q3
Q2 2015 $2,391,000 $335,000 -$446,000 -57% 01 Apr 2015 30 Jun 2015 10-Q 10 Aug 2016 2016 Q2
Q1 2015 $2,837,000 $599,000 -$104,000 -15% 01 Jan 2015 31 Mar 2015 10-Q 12 May 2016 2016 Q1
Q4 2014 $2,941,000 $600,000 -$6,000 -0.99% 01 Oct 2014 31 Dec 2014 10-K 29 Mar 2016 2015 FY
Q3 2014 $2,947,000 $857,000 +$216,000 +34% 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015 2015 Q3
Q2 2014 $2,731,000 $781,000 +$174,000 +29% 01 Apr 2014 30 Jun 2014 10-Q 10 Aug 2015 2015 Q2
Q1 2014 $2,557,000 $703,000 +$347,000 +97% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015 2015 Q1
Q4 2013 $2,210,000 $606,000 -$527,000 -47% 01 Oct 2013 31 Dec 2013 10-K 16 Mar 2015 2014 FY
Q3 2013 $2,737,000 $641,000 +$167,000 +35% 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2014 2014 Q3
Q2 2013 $2,570,000 $607,000 +$201,000 +50% 01 Apr 2013 30 Jun 2013 10-Q 07 Aug 2014 2014 Q2
Q1 2013 $2,369,000 $356,000 -$42,000 -11% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014 2014 Q1
Q4 2012 $2,411,000 $1,133,000 01 Oct 2012 31 Dec 2012 10-K 16 Mar 2015 2014 FY
Q3 2012 $474,000 +$326,000 +220% 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013 2013 Q3
Q2 2012 $406,000 +$223,000 +122% 01 Apr 2012 30 Jun 2012 10-Q 08 Aug 2013 2013 Q2
Q1 2012 $398,000 01 Jan 2012 31 Mar 2012 10-Q 07 May 2013 2013 Q1
Q3 2011 $148,000 01 Jul 2011 30 Sep 2011 10-Q 14 Nov 2012 2012 Q3
Q2 2011 $183,000 01 Apr 2011 30 Jun 2011 10-Q 14 Aug 2012 2012 Q2

WINDTREE THERAPEUTICS INC /DE/ Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $455,000 -$823,000 -64% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
2023 $1,278,000 -$1,808,000 -59% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
2022 $3,086,000 -$4,152,000 -57% 01 Jan 2022 31 Dec 2022 10-K 16 Apr 2024 2023 FY
2021 $7,238,000 +$1,554,000 +27% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $5,684,000 -$1,037,000 -15% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2019 $6,721,000 +$5,766,000 +604% 01 Jan 2019 31 Dec 2019 10-K 29 Mar 2021 2020 FY
2018 $955,000 -$606,000 -39% 01 Jan 2018 31 Dec 2018 10-K 03 Apr 2020 2019 FY
2017 $1,561,000 +$138,000 +9.7% 01 Jan 2017 31 Dec 2017 10-K/A 23 Apr 2019 2018 FY
2016 $1,423,000 -$273,000 -16% 01 Jan 2016 31 Dec 2016 10-K 17 Apr 2018 2017 FY
2015 $1,696,000 -$1,245,000 -42% 01 Jan 2015 31 Dec 2015 10-K 31 Mar 2017 2016 FY
2014 $2,941,000 +$731,000 +33% 01 Jan 2014 31 Dec 2014 10-K 29 Mar 2016 2015 FY
2013 $2,210,000 -$201,000 -8.3% 01 Jan 2013 31 Dec 2013 10-K 16 Mar 2015 2014 FY
2012 $2,411,000 +$1,544,000 +178% 01 Jan 2012 31 Dec 2012 10-K 16 Mar 2015 2014 FY
2011 $867,000 -$543,000 -39% 01 Jan 2011 31 Dec 2011 10-K 17 Mar 2014 2013 FY
2010 $1,410,000 01 Jan 2010 31 Dec 2010 10-K 15 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.